Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Reply to thread

Message

If you're already making $180k I'd be cautious. Sure, you could make $200, $225, or even more. But consistently? Not in this market. EV3 has made their name with decent products with rock bottom pricing. Now that they are part of COV, that will change. COV will not be the low cost leader long term. Unfortunately, I dont see EV3 coming with anything game changing. Their stent, if they didn't price it at $800 and less, would not get pulled. Their balloons are below average. Their carotid system is below average. Their BX stent is non existant. No CTO products. No IVC filter. Athrectomy is probably the 3rd best on the market. Good company, but I see their recent growth coming from being a part of COV and taking advantage of what that offers, not from having great products. I don't see sustainability long term. If you are truly making $180, I don't think the risk is worth the upside.

<blockquote data-quote="Anonymous" data-source="post: 4358481"><p>If you're already making $180k I'd be cautious.&nbsp; Sure, you could make $200, $225, or even more.&nbsp; But consistently?&nbsp; Not in this market.&nbsp; EV3 has made their name with decent products with rock bottom pricing.&nbsp; Now that they are part of COV, that will change.&nbsp; COV will not be the low cost leader long term.&nbsp; Unfortunately, I dont see EV3 coming with anything game changing.&nbsp; Their stent, if they didn't price it at $800 and less, would not get pulled.&nbsp; Their balloons are below average.&nbsp; Their carotid system is below average.&nbsp; Their BX stent is non existant. No CTO products. No IVC filter. Athrectomy is probably the 3rd best on the market.&nbsp; Good company, but I see their recent growth coming from being a part of COV and taking advantage of what that offers, not from having great products.&nbsp; I don't see sustainability long term.&nbsp; If you are truly making $180, I don't think the risk is worth the upside.</p></blockquote><p></p>

[QUOTE="Anonymous, post: 4358481"] If you're already making $180k I'd be cautious. Sure, you could make $200, $225, or even more. But consistently? Not in this market. EV3 has made their name with decent products with rock bottom pricing. Now that they are part of COV, that will change. COV will not be the low cost leader long term. Unfortunately, I dont see EV3 coming with anything game changing. Their stent, if they didn't price it at $800 and less, would not get pulled. Their balloons are below average. Their carotid system is below average. Their BX stent is non existant. No CTO products. No IVC filter. Athrectomy is probably the 3rd best on the market. Good company, but I see their recent growth coming from being a part of COV and taking advantage of what that offers, not from having great products. I don't see sustainability long term. If you are truly making $180, I don't think the risk is worth the upside. [/QUOTE]

Name

Verification

Top Bottom

Back